Relapsing nephrotic syndrome.
D002216:Captopril / Q000627:therapeutic use; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003524:Cyclosporins / Q000627:therapeutic use; D005920:Glomerular Mesangium / Q000473:pathology; D006801:Humans; D007105:Immune Complex Diseases / Q000473:pathology; D007111:Immunity, Cellular / Q000187:drug effects; D007075:Immunoglobulin M / Q000378:metabolism; D007978:Levamisole / Q000627:therapeutic use; D008222:Lymphokines / Q000378:metabolism; D009402:Nephrosis, Lipoid / Q000473:pathology; D009404:Nephrotic Syndrome / Q000188:drug therapy / Q000473:pathology*; D012008:Recurrence; D013256:Steroids / Q000627:therapeutic use
D003524:Cyclosporins; D007075:Immunoglobulin M; D008222:Lymphokines; D013256:Steroids; D002699:Chlorambucil; D007978:Levamisole; D003520:Cyclophosphamide; D002216:Captopril